Advertisement

Latest News

Q&A: IL-23, Oral Therapies, and Inflammatory Disease Management, With April W. Armstrong, MD, MPH

6 hours ago

Armstrong spoke in an interview regarding several different sessions presented at the 2026 AAD meeting.

OX40 for Atopic Dermatitis: A Target at a Crossroads

12 hours ago

Severe Obesity Linked to Distinct Myocardial Dysfunction in HFpEF

13 hours ago

Kass explains 2 distinct biological subgroups discovered in HFpEF and how they relate to a paradigm shift.

Diabetes Dialogue: Nutrition, Medication, and Treatment in Obesity With Elizabeth Bauer, MD

23 hours ago

Elizabeth Bauer, MD, joins the show to discuss her AACE 2026 presentation on key updates in obesity management and nutrition.

Crinecerfont Reduces Glucocorticoid Doses in CAH, With Richard Auchus, MD, PhD

April 24, 2026

Auchus discusses the 2-year results from CAHtalyst Adult, highlighting the substantial retention rates over the open-label extension period.

Advertisement
Advertisement